In circulation, the vast majority of IGF-1 exists bound to one of the IGFBPs, with IGFBP-3 accounting for approximately 80% of all binding
GHK-Cu (Gly-His-Lys copper complex) is studied for collagen synthesis and extracellular matrix remodeling
Potential side effects may include injection-site redness, swelling, bruising, itching, tenderness, small lumps, headache, fatigue, nausea, appetite changes, abdominal discomfort, stool changes, dizziness, altered sleep, mood changes, or feeling off. Allergic or immune reactions are also possible, and the FDA has specifically raised concerns about immunogenicity and peptide-related impurities in compounded BPC-157
When to Use Injections Injections are best suited for patients who are looking for rapid results, especially those who are dealing with significant energy depletion or metabolic issues